ArticleExperimental and therapeutic medicine2022

SPRR3, a novel miR-338-3p target, regulates the malignant progression of clear cell renal cell carcinoma

Man Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.